HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Growth of an aggressive tumor during pregnancy in an acromegalic patient.

Abstract
Pregnancy in acromegalic patients is a rare event, but is usually uneventful, with stable GH and IGF-I levels and no tumor enlargement. Medical treatment can usually be withdrawn without problems and although no major adverse event has been reported, the suspension of drug treatments is generally recommended. No case report exists in the literature regarding evolution of a somatotropinoma with invasiveness markers throughout pregnancy. We report a case of an acromegalic patient who was submitted to surgery and treated with octreotide LAR maintaining a stable residual tumor and an IGF-I close to the normal levels. Her tumor presented with a high Ki-67 (11.6%) and a low aryl hydrocarbon receptor-interacting protein (AIP) expression. When she became pregnant, octreotide LAR was withdrawn, and despite remaining asymptomatic during pregnancy, tumor growth occurred with compression of surrounding structures. In conclusion, pregnancy in acromegalic patients has usually a favorable prognosis with no tumor growth. However, in the presence of high Ki-67 labeling index and low AIP expression, tumor enlargement may occur and somatostatin analogue treatment throughout the pregnancy should be considered.
AuthorsLeandro Kasuki, Leonardo Vieira Neto, Christina M Takiya, Mônica R Gadelha
JournalEndocrine journal (Endocr J) Vol. 59 Issue 4 Pg. 313-9 ( 2012) ISSN: 1348-4540 [Electronic] Japan
PMID22240890 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Intracellular Signaling Peptides and Proteins
  • Ki-67 Antigen
  • aryl hydrocarbon receptor-interacting protein
  • Insulin-Like Growth Factor I
  • Octreotide
Topics
  • Acromegaly (complications, radiotherapy, surgery)
  • Female
  • Humans
  • Insulin-Like Growth Factor I (metabolism)
  • Intracellular Signaling Peptides and Proteins (genetics, metabolism)
  • Ki-67 Antigen (analysis)
  • Octreotide (therapeutic use)
  • Pituitary Neoplasms (drug therapy, pathology, radiotherapy, surgery)
  • Postpartum Period
  • Pregnancy
  • Pregnancy Complications, Neoplastic (pathology, surgery)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: